People with sarcoidosis are being asked to donate blood samples and information related to their disease to help the…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
People with sarcoidosis who have impaired lung function seem to be at greater risk for severe COVID-19Â disease, a…
A grant from the Foundation for Sarcoidosis Research (FSR) will fund the development of a new mouse model of…
Protalix BioTherapeutics and SarcoMed USA have entered into a non-binding agreement related to the development and commercialization of…
People with sarcoidosis-associated pulmonary hypertension who have reduced physical fitness or worse gas exchange capacity live significantly shorter times…
Sarcoidosis affecting the spinal cord tends to result in distinct patterns visible on MRIs of the spine, which…
The American Thoracic Society has published its first official guidelines for how best to detect and diagnosis sarcoidosis in clinical…
Results of a Phase 1b/2a clinical study evaluating ATYR1923 in people with pulmonary sarcoidosis are likely to be delayed…
Boehringer Ingelheim‘s Ofev (nintedanib) has been approved in the U.S. as the first treatment for chronic fibrosing interstitial…
aTyr Pharma announced a collaboration and license agreement with Kyorin Pharmaceutical to develop and commercialize ATYR1923, its potential…